TMCnet News
Research and Markets: Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014: Espy the Commercial Landscape of the Major Universities / Institutes / Hospitals & CompaniesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/7xqwcl/guillainbarre) has announced the addition of the "Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014" report to their offering. "Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Guillain-Barre Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Guillain-Barre Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary overage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Guillain-Barre Syndrome. Scope
Clinical Trial Overview of Top Companies
Clinical Trial Overview of Top Institutes / Government
For more information visit http://www.researchandmarkets.com/research/7xqwcl/guillainbarre
|